Skip to main
CI
CI logo

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 34 analyst ratings
Buy
Strong Buy 32%
Buy 47%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is poised for a positive financial trajectory, with a projected modified CY25 pre-tax adjusted operating income of $4,175 million, marking a year-over-year increase of 7.0%. The company's Evernorth segment is also expected to show solid growth, with an estimated 5.8% year-over-year increase in earnings, driven by robust specialty volume growth, including the adoption of biosimilars and expansion in clinical care services. Additionally, significant improvements in the Stop-Loss Medical Loss Ratio (MLR) are forecasted, with an anticipated decline from 91.0% in CY26 to a new target of 89.0% in CY27, reflecting Cigna's ongoing strategic investments and operational efficiencies.

Bears say

The Cigna Group experienced a significant earnings miss in the fourth quarter of 2024, with adjusted EPS reported at $6.64, representing a 15% shortfall against consensus estimates and reflecting a 2.2% year-over-year decline. The company faced unfavorable medical membership trends, reporting a total enrollment of 19.147 million, which marks a 3.2% year-over-year decrease, primarily driven by challenges in the Individual and Family Plans category due to pricing actions in select markets. Additionally, the elevated incidence of high-cost claimants in the Stop-Loss segment exacerbated the challenges faced by Cigna, contributing to overall pressure on its financial performance and outlook.

Cigna (CI) has been analyzed by 34 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 47% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 34 analysts, Cigna (CI) has a Buy consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $316.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $316.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.